Loading…
← CockpitCompetitor Analysis › 603990.SS Suzhou MedicalSystem Technology Co., Ltd. Class AOpen in the cockpit ↗

Suzhou MedicalSystem Technology Co., Ltd. Class A603990.SSCompetitor analysis, valuation and peers

China · CNY·Information Technology›Packaged Software
Momentum leader 99
Mkt cap
$1.04B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$53.9M
20-day average traded
Fwd P/E
95.1×
forward earnings
ROIC−WACC
-6.0 pp
WACC 7.9%
Hurdle
n/a
no reverse DCF
Next earnings
171 days
26 Apr 2027
Close · CNYCN¥22.83
1D+0.6%
1W+21.0%
1M+19.8%
3M+39.8%
6M+44.3%
YTD+50.5%
1Y+52.6%
ATR %5.1%
52w lowhigh8.8% off high

What Suzhou MedicalSystem Technology does

Employees: 632

Suzhou MedicalSystem Technology at a glance

Size Suzhou MedicalSystem Technology (603990.SS) is a China Information Technology company (Packaged Software) with a market value of $1.04B, the 2233rd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥22.83 on 6 Nov 2026.

Performance Over six months the shares gained 44.3%, against -21.8% for the median peer and -16.4% for the China market (cap-weighted) — 3rd highest of 20 in its peer set.

Growth Revenue fell 15.0% over the last twelve months (peer median +8.5%); the operating margin is 5.5% (peer median -0.4%).

Valuation It trades at 95.1× forward earnings against a peer median of 29.0× (most expensive of 11).

Capital Return on invested capital runs 6.0 points below its cost of capital (7.9% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026603990.SS 147Peer median 76
Six months, rebased to 100: Suzhou MedicalSystem Technology against the median of its 20 peers (local-currency closes).

Suzhou MedicalSystem Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥289MCN¥300MCN¥462MCN¥615MCN¥303M
Revenue growth—-35%-25%+103%—
Gross profitCN¥146MCN¥159MCN¥37.9MCN¥101MCN¥204M
EBITDACN¥52.8MCN¥48.9M-CN¥154M-CN¥198MCN¥37.5M
Net incomeCN¥17.5MCN¥39.2M-CN¥279M-CN¥269MCN¥33.6M
Free cash flowCN¥33.8M-CN¥2.21M-CN¥261M-CN¥907MCN¥33.4M
Capital expenditureCN¥37.3MCN¥68.6MCN¥252MCN¥600MCN¥24.6M
Total debtCN¥231MCN¥276MCN¥426MCN¥1.86BCN¥163M

Quarterly statements and history in the cockpit →

Suzhou MedicalSystem Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-50%-25%0%+25%3004672889GTMBVSBBAI2391BSOFTBLACKBUCK30087230124874SW293490RDVTRSKD2526603990.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Suzhou MedicalSystem Technology is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×50×100×GTMBVSBSOFTBLACKBUCK30087230034830124874SWRDVTRSKD603990.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Suzhou MedicalSystem Technology is the large dot.

Suzhou MedicalSystem Technology competitors and peer comparison

How Suzhou MedicalSystem Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Suzhou MedicalSystem Technology against its 20 peers (data as of 6 Nov 2026)
Measure603990.SSPeer medianRank in peer set
1-month return+19.8%-5.2%3rd highest of 21
6-month return+44.3%-21.8%3rd highest of 20
Distance from 52-week high-8.8%-37.7%3rd highest of 21
Revenue growth (TTM)-15.0%+8.5%2nd lowest of 21
Operating margin5.5%-0.4%8th highest of 21
Forward P/E95.1×29.0×most expensive of 11
ROIC minus cost of capital-6.0 pp-8.1 pp9th highest of 19
Net debt / EBITDA-4.9×-1.1×2nd least indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Suzhou MedicalSystem Technology 603990.SSChina$1.04B+44%-15%5%95.1×n/an/a
Sichuan Xun You Network Technology 300467.SZChina$1.05B-22%+2%1%n/an/an/a
PATEO CONNECT Technology (Shanghai) 2889.HKHong Kong$1.05B-65%+72%-24%n/an/an/a
ZoomInfo Technologies GTMUnited States$1.02B-45%+3%23%3.1×-9.7%+21.3%
Bravura Solutions BVS.AXAustralia$1.06B+50%-10%25%24.3×4.1%+3.1%
BigBear.ai BBAIUnited States$1.07B-47%-1%-66%n/an/an/a
Tuya 2391.HKHong Kong$1.00B-33%+7%5%n/an/an/a
Birlasoft BSOFT.NSIndia$998M-7%+4%15%14.8×7.9%+8.4%
Blackbuck BLACKBUCK.NSIndia$1.08B-1%+50%14%52.8×34.8%+54.8%
Bingo Software 688227.SSChina$1.08B-56%-7%-11%n/an/an/a
Tansun Technology 300872.SZChina$1.08B-11%-10%-12%70.3×n/an/a
Shenzhen Sunline Tech 300348.SZChina$1.10B-22%+19%-1%84.3×n/an/a
Chengdu Information Technology of Chinese Academy of Sciences 300678.SZChina$969M-24%+100%0%n/an/an/a
Nexwise Intelligence China 301248.SZChina$967M-47%+11%13%30.6×n/an/a
74Software 74SW.PAFrance$1.11B-5%+11%14%13.3×-1.7%+18.9%
Shiprocket SHIPROCKET.NSIndia$963Mn/a+24%-5%n/a56.2%+23.0%
Kakao Games 293490.KSSouth Korea$962M+3%-21%-27%n/an/an/a
Red Violet RDVTUnited States$1.12B+41%+20%18%40.3×39.4%+21.1%
GuoChuang Software 300520.SZChina$955M-40%-14%-12%n/an/an/a
Riskified RSKDUnited States$1.13B+78%+10%-4%27.3×12.6%+15.3%
Hangzhou Diagens Biotechnology 2526.HKHong Kong$1.13B-68%+134%-49%n/an/an/a

Questions

Which companies are Suzhou MedicalSystem Technology's closest peers?
The cockpit's peer set: Sichuan Xun You Network Technology (300467.SZ), PATEO CONNECT Technology (Shanghai) (2889.HK), ZoomInfo Technologies (GTM), Bravura Solutions (BVS.AX), BigBear.ai (BBAI), Tuya (2391.HK), Birlasoft (BSOFT.NS), Blackbuck (BLACKBUCK.NS).
Is Suzhou MedicalSystem Technology expensive compared with its peers?
On forward p/e it trades at 95.1× against a peer median of 29.0×, most expensive of 11 in its peer set.
How has Suzhou MedicalSystem Technology stock performed?
Over six months to 6 Nov 2026 the shares returned +44.3% against -21.8% for the median peer; over one year +52.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.